Showing results (311-320 of 329) with videos related to

Sort By:
Pageof 33
Vaccines|June 27, 2024
Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case-Control StudyAmy Keane, Ashley Tippett, Elizabeth Grace Taylor, et al.
Vaccines|January 28, 2026
mRNA COVID-19 Vaccine Effectiveness Against Severe Outcomes Among Adults Hospitalized with COVID-19 from May 2021 to January 2023Gabriella Ess, Ashley M Lew, Ashley Tippett, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2022
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 StudyAdam D Cohen, Parameswaran Hari, Myo Htut, et al.
Cell Reports. Medicine|May 3, 2023
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trialTulika Ranjan, Soma Sengupta, Michael J Glantz, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple MyelomaLuciano J Costa, Yi Lin, R Frank Cornell, et al.
Diabetes, Obesity & Metabolism|July 6, 2026
Semaglutide Injection Once-Weekly for Weight Management in Adults: Results From A Randomized Phase III, Active-Controlled StudyUnnikrishnan Ambika Gopalakrishnan, Ameya Joshi, Harish Kumar, et al.
Plos One|February 11, 2026
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platformHannah R Volkman, Leonie de Munter, Jennifer L Nguyen, et al.
Eclinicalmedicine|December 27, 2024
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformJennifer L Nguyen, Marianna Mitratza, Hannah R Volkman, et al.
Current Medical Research and Opinion|July 11, 2022
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myelomaLuciano J Costa, Parameswaran Hari, Jesus G Berdeja, et al.
The Indian Journal of Medical Research|April 23, 2026
Diagnostic accuracy and safety of Cy-Tb for detection of tuberculosis infection: A multicentric study from IndiaManjula Singh, Tahziba Hussain, Bhavesh Modi, et al.
Pageof 33